Anatara Lifesciences Ltd has released a press release.
Operational Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Q4 FY22 Activities Report
- Quarterly Appendix 4C Cash Flow Report
- Clinical Trial and Operational Update
- Anatara Lifesciences announces leadership change
- Appendix 4C and Q3 FY22 Activities Report
Later from Anatara Lifesciences
- Appendix 4E & Audited Financial Report 30 June 2022
- 3FDC Clinical Trial update
- Anatara Investor Presentation
- Entitlement Offer Prospectus
- Placement and Entitlement Offer
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences